Assessing Intra-arterial Complications of Planning and Treatment Angiograms for Y-90 Radioembolization

  • Osman Ahmed
  • Mikin V. Patel
  • Abdulrahman Masrani
  • Bradford Chong
  • Mohammed Osman
  • Jordan Tasse
  • Jayesh Soni
  • Ulku Cenk Turba
  • Bulent Arslan
Clinical Investigation

Abstract

Purpose

To report hepatic arterial-related complications encountered during planning and treatment angiograms for radioembolization and understand any potential-associated risk factors.

Materials and Methods

518 mapping or treatment angiograms for 180 patients with primary or metastatic disease to the liver treated by Yttrium-90 radioembolization between 2/2010 and 12/2015 were retrospectively reviewed. Intra-procedural complications were recorded per SIR guidelines. Patient demographics, indication for treatment, prior exposure to chemotherapeutic agents, operator experience, and disease burden were reviewed. Technical variables including type of radioembolic (glass vs. resin microspheres), indication for angiography (mapping vs. treatment), variant anatomy, and attempts at coil embolization were also assessed.

Results

Thirteen (13/518, 2.5%) arterial-related complications occurred in 13 patients. All but two complications resulted during transcatheter coil embolization to prevent non-target embolization. Complications included coil migration (n = 6), arterial dissection (n = 2), focal vessel perforation (n = 2), arterial thrombus (n = 2), and vasospasm prohibiting further arterial sub-selection (n = 1). Transarterial coiling was identified as a significant risk factor of complications on both univariate and multivariate regression analysis (odds ratio 7.8, P = 0.004). Usage of resin microspheres was also a significant risk factor (odds ratio 9.5, P = 0.042). No other technical parameters or pre-procedural variables were significant after adjusting for confounding on multivariate analysis (P > 0.05).

Conclusion

Intra-procedural hepatic arterial complications encountered during radioembolization were infrequent but occurred mainly during coil embolization to prevent non-target delivery to extra-hepatic arteries.

Keywords

Radioembolization Complication Selective internal radiation therapy Arterial complication 

Notes

Compliance with Ethical Standards

Conflict of interest

Bulent Arslan is a speaker and advisory board member for Penumbra®, Medtronic/Covidien®, and speaker for Cook®, W.L. Gore®, Guerbet®, and CR Bard®.

References

  1. 1.
    Kennedy AS, McNeillie P, Dezarn WA, et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys. 2009;74:1494–500.CrossRefPubMedGoogle Scholar
  2. 2.
    Lewandowski RJ, Memon K, Mulcahy MF, et al. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Mol Imaging. 2014;41:1861–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011;140:497–507.CrossRefPubMedGoogle Scholar
  4. 4.
    Riaz A, Lewandowski RJ, Kulik LM, et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009;20:1121–30.CrossRefPubMedGoogle Scholar
  5. 5.
    Cosin O, Bilbao JI, Alvarez S, et al. Right gastric artery embolization prior to treatment with yttrium-90 microspheres. Cardiovasc Interv Radiol. 2007;30:98–103.CrossRefGoogle Scholar
  6. 6.
    Maleux G, Wolter P, Vanslembrouck R, et al. Unexpected ischemic complication after proximal coil embolization of a replaced left hepatic artery before yttrium-90 radioembolization. J Vasc Interv Radiol. 2013;24:1745–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Brown DB. Hepatic artery dissection in a patient on bevacizumab resulting in pseudoaneurysm formation. Semin Interv Radiol. 2011;28:142–6.CrossRefGoogle Scholar
  8. 8.
    Singh H, Cardella JF, Cole PE, et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol. 2003;14:S283–8.PubMedGoogle Scholar
  9. 9.
    Wiggins E, Ibrahim SM, Lewandowski RJ, et al. Effect of chemotherapy on hepatic vasculature in patients undergoing Y-90 radioembolization for metastatic disease. Presented at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology. 19 Mar 2008.Google Scholar
  10. 10.
    Lewandowski RJ, Salem R. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Semin Interv Radiol. 2006;23:64–72.CrossRefGoogle Scholar
  11. 11.
    Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer. 2008;112:1538–46.CrossRefPubMedGoogle Scholar
  12. 12.
    Murthy R, Eng C, Krishnan S, et al. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol. 2007;18:1588–91.CrossRefPubMedGoogle Scholar
  13. 13.
    Fischman AM, Ward TJ, Patel RS, et al. Prospective, randomized study of coil embolization versus surefire infusion system during yttrium-90 radioembolization with resin microspheres. J Vasc Interv Radiol. 2014;25:1709–16.CrossRefPubMedGoogle Scholar
  14. 14.
    Morshedi MM, Bauman M, Rose SC, et al. Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection. Cardiovasc Interv Radiol. 2015;38:381–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017

Authors and Affiliations

  1. 1.Section of Interventional Radiology, Department of RadiologyRush University Medical CenterChicagoUSA
  2. 2.Department of RadiologyUniversity of ChicagoChicagoUSA

Personalised recommendations